17-74704696-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_139018.5(CD300LF):c.164G>A(p.Arg55Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000209 in 1,614,198 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_139018.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD300LF | NM_139018.5 | c.164G>A | p.Arg55Gln | missense_variant | 2/7 | ENST00000326165.11 | NP_620587.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD300LF | ENST00000326165.11 | c.164G>A | p.Arg55Gln | missense_variant | 2/7 | 1 | NM_139018.5 | ENSP00000327075.6 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000386 AC: 97AN: 251492Hom.: 0 AF XY: 0.000390 AC XY: 53AN XY: 135922
GnomAD4 exome AF: 0.000211 AC: 308AN: 1461890Hom.: 1 Cov.: 30 AF XY: 0.000228 AC XY: 166AN XY: 727246
GnomAD4 genome AF: 0.000197 AC: 30AN: 152308Hom.: 0 Cov.: 32 AF XY: 0.000242 AC XY: 18AN XY: 74476
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 08, 2024 | The c.164G>A (p.R55Q) alteration is located in exon 2 (coding exon 2) of the CD300LF gene. This alteration results from a G to A substitution at nucleotide position 164, causing the arginine (R) at amino acid position 55 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at